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OBJECTIVES The present study intended to evaluate the clinical profile and outcome in a large cohort of
pediatric patients with idiopathic ventricular tachycardia (VT).
BACKGROUND Ventricular tachycardia (VT) without underlying heart disease is rare in childhood. Limited
information is available with regard to outcome and indications for long-term antiarrhythmic
treatment.
METHODS A retrospective multicenter study was conducted. Patient data were obtained from the
individual centers using a standardized questionnaire.
RESULTS Ninety-eight pediatric patients with episodes of VT in the absence of structural heart disease
were included. Mean age at first manifestation of the arrhythmia was 5.4 years (range 0.1 to
15.1), with 27% of the patients having had VT already in infancy. Clinical symptoms or
echocardiographic signs of left ventricular dysfunction were observed initially in 36% of the
patients, of which one third (12% of the whole population) presented with severe symptoms
(heart failure or syncope). After a mean follow-up of 47 months (range 12 to 182), no patient
had died. Twenty-five patients had never been treated with antiarrhythmic drugs. Sixty-three
patients were free of VT and did not take antiarrhythmic drugs at last follow-up. Prognosis
was better when VT occurred during the first year of life (VT resolution in 89%) compared
with VT occurrence beyond the first year of life (VT resolution in 56%: p , 0.01). The
clinical profile was more favorable for patients with presumed right VT (VT resolution in
76%, symptoms in 25% of patients) compared with patients with presumed left VT, where
VT resolution occurred in 37% and symptoms in 67% of patients (p , 0.01).
CONCLUSIONS VT in children with a normal heart carried a good prognosis. Outcome was better after onset
of VT during infancy and when VT originated in the right ventricle. A restrictive use of
antiarrhythmic agents might be justified in a large proportion of these patients. (J Am Coll
Cardiol 1999;33:2067–72) © 1999 by the American College of Cardiology
Idiopathic ventricular tachycardia (VT) refers to a clinical
entity observed in children and adults, in whom conven-
tional diagnostic evaluation fails to detect structural heart
disease. For years, reports on small pediatric series have
focused the attention on that arrhythmia (1–7). It was found
that idiopathic VT basically carried a good prognosis, but
due to the small numbers of patients reported, the risk
profile of that condition still awaits clarification because the
reports published have only included between 4 and 26
children with VT and normal hearts (3,5).
Guidelines for treatment of such patients are far from
being established; it was advocated that therapy could be
withheld in most patients (3,5) or that only symptomatic
children should be treated (4). Conversely, radiofrequency
ablation has been shown to be an effective treatment option
in such patients, and even asymptomatic children had been
treated that way (8), an approach that did not remain
undebated (9).
We attempted to further elucidate the clinical profile and
the outcome of infants and children with idiopathic VT. On
the basis of a multi-institutional experience, we are report-
ing on the largest population of pediatric patients with
idiopathic VT.
METHODS
Patient selection. The study was conducted by members of
the Working Group on Arrhythmias and Electrophysiology
of the Association for European Pediatric Cardiology (see
Appendix for list of participating institutions). Children
diagnosed and followed at one of the participating centers
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for the occurrence of ventricular tachycardia were studied.
The VT diagnosis was based on accepted criteria (10,11) in
any child showing at least three consecutive ventricular
complexes at a rate clearly faster than the child’s sinus
rhythm, and documented on surface electrocardiogram
(ECG) or a Holter monitor. Episodes of VT were defined
as sustained when lasting .30 s, otherwise, they were
defined as nonsustained.
Children were included if they presented with docu-
mented episodes of VT between January 1985 and Decem-
ber 1995. Patients of the whole pediatric age range (neona-
tal up to #16 years) at the time of first manifestation of VT
were included. Inclusion required a follow-up of each
individual child of .1 year; shorter follow-up periods were
only considered for inclusion in case the affected child had
died. The children had to be studied with repetitive Holter
monitors and echocardiograms. Exclusion of structural
heart disease was required at least by a complete two-
dimensional and Doppler echocardiographic study.
All patients with signs of structural heart disease of any
kind or with previous cardiac surgery, as well as patients
with clinical or laboratory signs of systemic or inflammatory
disease at initial presentation, were excluded. Patients with
chronic systemic disease of any kind were also not eligible
for the study.
Patients with so-called accelerated ventricular rhythm,
defined as ventricular rate only #20% faster than the child’s
concurrent sinus rhythm, were excluded (12). Prolongation
of the corrected QT interval ($440) in the resting ECG
excluded patients from evaluation for the present study.
Finally, patients with catecholaminergic VT (13), defined as
occurrence of syncope due to polymorphic VT during
exercise, were also not eligible for the present study.
Collection of data. The study was conducted as a retro-
spective, multicenter evaluation, and data for the individual
patient were obtained from the participating centers by
means of a standardized questionnaire. The questionnaires
of all patients were evaluated by the study coordinators (JPP,
TP). Surface ECGs and tracings of VT episodes, also
requested for all patients, were reevaluated by the authors
for decision of exclusion of patients in a blinded fashion.
Definitions. Resolution of VT was defined as lack of
evidence of recurrences clinically and during Holter moni-
tors. Complete success of drug treatment was defined as
cessation of documented VT after any given newly intro-
duced drug had reached its steady state. A partial effect of a
drug was considered if episodes of VT were significantly less
frequent (drop in number of VT episodes of .50%), if the
heart rate during VT decreased by .20% or if sustained VT
changed to only nonsustained VT episodes after introduc-
tion of a new drug.
Statistics. Descriptive data were characterized by the mean
(median where appropriate) with standard deviation and the
range. Patient groups were compared using the paired or
unpaired t test where appropriate. Relative frequencies
observed between different groups of patients were com-
pared using the chi-square test; for small sample sizes,
Fisher exact test was used. A p value ,0.05 was considered
statistically significant.
RESULTS
Patients’ characteristics. Data on 127 pediatric patients
were collected from 13 European centers. After data eval-
uation, 98 children from 12 centers were included in the
study. Reasons for exclusion of 29 patients were clearcut
QTc prolongation in two children and diagnosis of cat-
echolaminergic VT in 10 patients. Accelerated ventricular
rhythm was present in four patients. In 10 children, VT was
not adequately documented as required. Two children had
evidence for arrhythmogenic right ventricular dysplasia and
one child experienced one episode of VT only during a
diagnostic tilt-table testing. The 98 patients included
showed an unspecific sex distribution (53 male, 45 female).
Mean age at initial presentation with VT was 5.4 years
(range 0.1–15.1) for the whole study population. Twenty-
seven patients (27%) were in their first year of life, of which
17 were in the newborn age at initial manifestation (Fig. 1).
Characteristics of VT. Sustained VT was observed in 36
of the patients (36%) and was equally distributed between
the age groups (44% of infants and 34% of older children:
p 5 NS). In eight patients (six infants and two older
children) VT was almost incessant. No patient had docu-
mentation of polymorphous VT. Maximum heart rate
Abbreviations and Acronyms
ECG 5 electrocardiogram
LBBB 5 left bundle branch block
RBBB 5 right bundle branch block
VT 5 ventricular tachycardia
Figure 1. Age distribution of the patients included in the study.
Bars indicate absolute number of patients per year at first mani-
festation.
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during VT was 165-302/min (mean 206) for infants and
120-184/min (mean 172) for older children.
Further analysis was aimed at assessing the course of the
disease and the outcome of patients depending on the
presumed origin of VT, as defined by the ECG morphology
of the QRS complexes in the ECG during tachycardia: left
bundle branch block (LBBB) morphology for right VT and
right bundle branch block (RBBB) morphology for left VT,
which is adequate for VT in patients with normal hearts
(14). The LBBB pattern largely predominated and was seen
in 71/98 patients (70%, p , 0.01), and was even more
prevalent in the infant population (86% of infants) as
compared with older children (68% of children older than
one year). Ventricular tachycardia with LBBB pattern
differed significantly from VT with RBBB pattern in the
clinical profile, as only 25% of patients with right VT had
symptoms, compared with 67% of patients with left VT
(p , 0.01). Mean maximum heart rate in VT was not
different between the two groups (175 6 37 in right VT
compared with 182 6 38 in patients with left VT: p 5 NS).
With regard to final outcome, again, VT with LBBB
pattern showed a more favorable profile with resolution of
VT at last follow-up in 76% of patients, as compared with
VT resolution in 37% of children with RBBB morphology
during VT (p , 0.01; follow-up periods not different in the
two groups; Table 1).
Symptoms. Thirty-six of the 98 patients (36%) showed
symptoms at presentation of VT or during follow-up.
Symptoms were more frequent in children (30/71 or 38%)
than in infants (6/27 or 22%, p , 0.05). In 12 of these
symptomatic patients, symptoms were considered as severe:
4 patients experienced syncope due to documented VT, and
heart failure was observed in 8 patients; 4 of the infants
(15%) as compared with 4 of the older children (6%, p 5
NS). Mild symptoms in the other 24 patients consisted of
dizziness (n 5 6), palpitations (n 5 12) and exercise
intolerance (n 5 6). Left ventricular function as assessed by
echocardiography during sinus rhythm (decreased ejection
fraction or shortening fraction and/or left ventricular dila-
tation) was impaired in 11 of these patients (6 children and
5 infants) but in none of the asymptomatic patients. It was
assessed whether there was any relation between maximum
heart rate during VT and the occurrence of symptoms. In
children with a VT rate ,150/min, 75% (18/24) were
asymptomatic, whereas in children with VT rates between
150 and 200, 50% (17/35) were asymptomatic. Of those
with heart rates .200/min, again, 50% (6/12) were asymp-
tomatic. Statistically, this gave only a trend but was not
significant (p 5 0.07). For the infant group, the same
analysis showed a significant difference, with one out of 16
infants with VT rates ,200/min showing symptoms, com-
pared with 5 out of 11 infants with VT rates .200 (p ,
0.01). In symptomatic infants, mean maximum heart rate
during VT (226 6 43 beats/min) was significantly higher
than in asymptomatic infants (196 6 25; p , 0.05).
Compared with the whole study population, where sus-
tained episodes of VT occurred in 36% of patients, sustained
VT was observed in a significantly larger proportion of
symptomatic patients (20/36 or 56%; p , 0.01).
Diagnostic workup. Besides a complete echocardiographic
study and a chest X-ray, which was done in all patients,
additional diagnostic methods to exclude structural heart
disease were used in 31 patients. Nine children had exclu-
sion of structural abnormalities of the heart by magnetic
resonance imaging and 22 children had cardiac catheteriza-
tion for hemodynamic evaluation and angiography. In only
14 patients was a diagnostic electrophysiologic study per-
formed, initially with VT inducible in only five children.
Of the patients presenting with symptoms (n 5 36) 16
(44%), in addition to the echocardiographic study, had
further diagnostic tests such as magnetic resonance imaging
or cardiac catheterization for confirmation of a structurally
normal heart.
Drug treatment. Of all patients, 25 never received drug
therapy; 9/27 infants (33%) and 16/71 children (22%; p 5
NS). Forty patients received drug treatment initially, which
was withdrawn during the course of the disease after a mean
time of 23 months (1–142 months). Only three of these
patients had a relapse of VT after drug withdrawal.
At last follow-up, 23 patients still took antiarrhythmic
drugs, and there was a clear difference with regard to age at
first presentation. Only 2/27 patients (7%) with VT mani-
festation in infancy still required treatment, compared with
21/71 children (30%; p , 0.05) with first manifestation
Table 1. Comparison of Clinical Characteristics of Patients Depending on the QRS
Morphology During VT
RBBB
(Presumed Left VT)
LBBB
(Presumed Right VT)
p
Value
Infants 4/27 (14%) 23/71 (32%) , 0.05
Symptoms 18/27 (67%) 18/71 (25%) , 0.01
Max. heart rate in VT 182 6 38 beats/min 175 6 37 beats/min NS
VT resolution 10/27 (37%) 54/71 (76%) , 0.01
Ablation 4/27 (14%) 5/71 (7%) NS
LBBB 5 left bundle branch block morphology; RBBB 5 right bundle branch block morphology; VT 5 ventricular tachycardia.
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beyond infancy still treated at last observation. Follow-up
time was not different between the two age groups.
Of the 73 patients who received antiarrhythmic drugs in
the course of the disease, 44 (60%) were managed with one
single antiarrhythmic drug, whereas 29 patients had more
than two consecutive or concomitant antiarrhythmic agents.
Of these, six (all from the same center) even received four to
six antiarrhythmic drugs (Fig. 2).
A comparison of the efficacy (complete and partial suc-
cess) of the antiarrhythmic agents most widely used is
shown in Figure 3. The reported success rates were highest
for amiodarone (89% of treatments). Sotalol, the most
widely used single agent, showed a success rate of 62%. The
overall efficacy of beta-adrenergic blocking agents was low-
est of all drugs (35%).
Radiofrequency ablation. Ablation was attempted in nine
children in four centers. Ablation was conducted by pace
mapping. Success was defined as noninducibility of VT
immediately and 30 min after ablation. Mean age of the
patients at the time of the procedure was 8.4 years (range 2
to 13); there was no ablation attempted in an infant. In five
children, the indication for ablation was severity of symp-
toms together with failure of drug therapy to control VT. In
three additional patients, ablation was performed for the
presence of almost incessant VT (with left ventricular
dysfunction in one child but absence of symptoms in the
other two). In one asymptomatic child, ablation was done
because of failure of antiarrhythmic drug therapy. Mean
heart rate during VT in the patients that underwent ablation
(168/min) did not differ from the mean rate of VT in the
other children (172/min; p 5 NS). Of the 9 ablation
attempts, 7 were successful. The site of ablation was located
in the right outflow tract (n 5 5; two failures of ablation)
and in the left ventricular aspect of the interventricular
septum (n 5 4; all successful). Ablation was performed with
a mean interval of 20 months (1–58 months) after the first
VT manifestation.
Final outcome. After a mean follow-up of 47 months
(12–182 months), all the patients included in the study were
alive. Of the 98 children, 63 (including the 7 patients
successfully ablated) were free of all drugs and free of VT
recurrences (Fig. 4). Sixteen additional patients were also
free of VT but were still treated with antiarrhythmic drugs.
Nineteen patients (19%) still experienced episodes of VT,
and out of these children, 10 were not treated at the time of
last follow-up, and the remaining 9 patients still had
antiarrhythmic prophylaxis.
With regard to overall final outcome, there was no
difference between patients with sustained VT compared
with patients with nonsustained VT (VT resolution and no
medication in 53% of children with sustained and in 60% of
patients with nonsustained VT, p 5 NS). The only signif-
icant difference between these two groups was that all
attempts at ablation were performed in patients who had
experienced sustained VT (p , 0.01).
Clinically, 2/98 patients (2%) were symptomatic at last
follow-up: one patient had syncopes and the other child
Figure 2. Antiarrhythmic drug treatment. Number of concomit-
tant or consecutive antiarrhythmic agents given to the patients over
the whole study period is shown.
Figure 3. Effectiveness of the antiarrhythmic agents most fre-
quently used. Bars indicate the relative success rates (hatched bars,
partial effect; filled bars, complete success). Amio 5 amiodarone;
Bbl 5 beta-blocker, Flec 5 flecainide; Prop 5 Propafenone; Sot 5
sotalol; Vera 5 verapamil.
Figure 4. Status of the study patients at last follow-up. Sixty-three
percent of patients were free of ventricular tachycardia and free of
drug treatment, including the seven patients who underwent
successful catheter ablation.
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showed exercise intolerance; both were scheduled for an
ablation procedure. The other 96 patients (98%) were free of
symptoms, whether or not they still experienced VT attacks.
Echocardiographic evaluation showed that left ventricular
function was normal in all patients at last follow-up.
Comparison of age groups. The characteristics and the
outcome of the patients were studied with regard to the age
at first manifestation of VT: infants ,1 year of age at
presentation (n 5 27) were compared with the older
children (.1 year at first manifestation: n 5 71). Table 2
shows a comparison of relevant data. A significantly larger
proportion of children were symptomatic (38% vs. 22% of
infants, p , 0.05). The two age groups did not differ in the
proportion of patients showing sustained VT. There was
also no significant difference in the proportion of patients
that were always left untreated. The most significant differ-
ence was observed in the outcome of patients: at last
follow-up, only two of the infants (7%) were still taking
antiarrhythmic drugs, whereas that proportion in the group
of older children was 30% (p , 0.05). With regard to
resolution of VT, it was observed that in 89% of the infants,
VT had disappeared during follow-up, whereas in the older
children, resolution of VT was observed in only 56% of
patients (p , 0.01).
DISCUSSION
Idiopathic VT in the presence of an apparently normal heart
is observed in adults and rarely in children, and usually is a
monomorphic tachycardia. Different pathophysiological
mechanisms (reentry, triggered activity, automacity) have
been shown to be involved (14,15). Single institutional
experience usually is small (1,2,5), and generally accepted
guidelines on how to manage these children are still lacking.
Published pediatric studies on idiopathic VT have shown a
favorable prognosis for the children affected (2,3,5,6). The
results of the present study confirm the favorable overall
prognosis of this condition, and the lack of mortality is an
important finding of this large series. After a mean
follow-up of almost four years, no child with idiopathic VT
had died, only 19% of our patients continued to have
episodes of VT and most (98%) of the children were
asymptomatic.
Clinical profile. There were two main findings of the
present study. In contrast with what had been observed in
the smaller series of pediatric patients reported so far, age at
first manifestation of VT influenced the final outcome, and
onset of VT in infancy was associated with a higher
proportion of patients in whom VT resolved as compared
with older age (.1 year) at initial presentation. Further-
more, in the infant population, symptoms were less fre-
quent. This was proven in a previous study, but in a mixed
population of children with and without heart disease and
VT (6). Another factor influencing the final outcome was
the presumed site of origin of VT. The present study
showed that over an equal period of follow-up, VT with a
LBBB morphology of the QRS complexes (presumably
originating from the right ventricle) was associated with a
significantly smaller proportion of symptomatic patients,
and that resolution of VT was observed in a higher
proportion of patients compared with VT presumably orig-
inating from the left ventricle (RBBB pattern of QRS
complexes).
Structurally normal heart. The definition of a normal
heart is a matter of debate. It may be argued that by defining
the normal heart based only on echocardiography findings,
there might be a number of children included in the present
study with subtle structural changes of the heart undetected
by echocardiography. For instance, one recent study in
adults with only single but frequent premature right ven-
tricular contractions found subtle structural abnormalities in
the right ventricular myocardium by magnetic resonance
imaging in most patients (16). Several reports found an
association between VT in otherwise normal hearts of
pediatric patients and biopsy findings compatible with silent
myocarditis, and immunosuppressive treatment resulted in
improvement or resolution of VT (17,18). Moreover, it has
been observed that small intramyocardial tumors, unde-
tected by either echocardiography and hemodynamic as-
sessement at catheterization, were the source of permanent
VT in infants (19). Such subtle structural abnormalities
cannot be excluded by the design of the present study. On
the other hand, 44% of the symptomatic children in the
present study had additional diagnostic tests (magnetic
resonance imaging or cardiac catheterization), and no such
subtle structural changes had been observed. This is in
contrast to the findings of a previous study in children where
subtle structural changes could be diagnosed at cardiac
catheterization in most of the symptomatic patients with
idiopathic VT and normal echocardiographic findings (4).
Treatment. Whether or not children with idiopathic VT
needed drug treatment or even radiofrequency catheter
ablation has so far been based on (mostly limited) institu-
tional and individual experience. This was again observed in
the present study with quite divergent treatment strategies
Table 2. Comparison of Clinical Characteristics of VT
Depending on the Age at Initial Manifestation
Infants Children
p
Value
Number of patients 27 71
Symptoms initially 6 (22%) 30 (38%) , 0.05
Sustained VT 12 (44%) 24 (34%) NS
RBBB 4 (14%) 23 (32%) , 0.05
VT resolution 24 (89%) 40 (56%) , 0.01
Never treated 9 (33%) 16 (23%) NS
Still treated 2 (7%) 21 (30%) , 0.05
Follow-up 48 months 46 months NS
RBBB 5 right bundle branch block morphology.
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in the centers involved. In adult patients, a cautious use of
antiarrhythmic agents directed at the relief of symptoms has
been advocated (14). In light of the favorable course and
outcome of most patients reported in the present evaluation,
it may as well be advised that in children with idiopathic
VT, the potential benefit of antiarrhythmic drug therapy
should be carefully weighed against its inherent risks. On
the basis of the results presented, it may be concluded that
the asymptomatic child (including normal left ventricular
function and dimensions) with VT in a normal heart should
be followed closely, but could be managed without drug
treatment. If empiric drug treatment is required, it was
found, in accordance with a previous report (4), that the use
of amiodarone and verapamil resulted in suppression of VT
in a considerable number of patients, whereas treatment
with beta-blockers resulted in the lowest success rates. As an
alternative option, tailored drug therapy based on the results
of an electrophysiologic study could be used (15). As in
adults (20), radiofrequency catheter ablation has also been
successfully performed as a treatment for idiopathic VT in
children (8). The use of this treatment in asymptomatic
children has been debated (9), because the long-term effects
of ablation in the ventricles of the growing myocardium are
not well known at the present time. For the child with
symptoms who is not responsive to drug therapy, this option
must be considered.
Study limitations. Several points need to be addressed.
Because of the design as a retrospective and multicenter
study, the reported patients reflected different and some-
times divergent treatment strategies, especially with regard
to decisions for initiation and withdrawal of drug trials,
thus, medical treatment as outlined in the study resulted
from different clinical approaches to children with VT,
making a comparison of treatments difficult. Diagnosis of
VT origin was based in most cases on the analysis of QRS
morphology on the surface ECG during tachycardia. Al-
though this has been shown to be adequate for patients with
normal hearts, there might be some patients (e.g., septal
origin of VT) where origin of VT was misdiagnosed.
Conclusions. Ventricular tachycardia in children with a
normal heart carried a good long-term prognosis, and in
most of the patients affected, VT resolved. The clinical
profile and the prognosis were better after onset of VT
already in infancy and for VT with a LBBB morphology
and thus presumably originating from the right ventricle. As
long as there are no symptoms and the left ventricular
dimensions and function remain normal, a restrictive use of
antiarrhythmic treatment may be justified. If refractoriness
of VT to antiarrhythmic therapy occurs, catheter ablation
may be indicated in the symptomatic child.
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MD, Paris, France; Paul T, MD, Hannover, Germany;
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